Skip to content
TrialScanner

NCT06183216

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Phase 1CompletedSVALead

Registry record

Lead sponsor
Sinovac Research and Development Co., Ltd.
Conditions
Pneumococcal Infectious Disease
Primary completion
Mar 26, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06183216 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06183216: A Phase 1b Clinical Trial of... | TrialScanner